Life Scientist > Molecular Biology

CAREERS SPECIAL: Keeping the pace

17 September, 2002 by Graeme O'Neill

Australia's biotech industry is flourishing and the jobs are definitely out there, reports Graeme O'Neill


Benitec develops new knockout method for animal genes

16 September, 2002 by Melissa Trudinger

Queensland company Benitec has developed a new method of knocking out genes in animals, combining its proprietary RNA interference (RNAi) technology with standard transgenic techniques.


The fine art of getting funding

09 September, 2002 by Pete Young

The Centre of Bioinformatics and Biological Computing is a Western Australian research institute that has made thinking laterally about sources of funding into an art form.


GTG in third US licence deal

09 September, 2002 by Melissa Trudinger

Melbourne-based Genetic Technologies has licensed its non-coding DNA patents to a third US genomics company, Perlegen Sciences, for about $1.6 million in cash and securities.


CSIRO research tool enables broad searches

02 September, 2002 by Melissa Trudinger

A research tool from CSIRO has the ability to make it easier to get information on research activities in Australia's research institutions, universities and government departments.


Polymerat making a splash in the US

02 September, 2002 by Pete Young

An Australian company that designs super-efficient surfaces for biochip and microplate assay systems used in high throughput proteomics screening has touched off an avalanche of US interest.


Singapore feature: money talks

02 September, 2002 by Iain Scott

The next time you start to worry about the drain of Australian scientific talent leaving town for better opportunities overseas, it might pay to remember the words of the director of Singapore's Institute for Molecular and Cell Biology, Chris Tan. Tan shrugs off such worries to opine that in Singapore's case, "Ideally, we'd be a 15-year revolving door."


Interview: Big picture stuff

02 September, 2002 by Iain Scott

It seems appropriate that the global CEO of a company engaged in the visualisation business is inclined to look at the big picture. Apart from being larger-than-life in person, Silicon Graphics (SGI) chief Bob Bishop is one of those outspoken, opinionated CEOs journalists love - one who is prepared to talk outside the finite square of profits and bottom lines to offer a world view.


Top WEHI researcher lured to UQ

30 August, 2002 by Pete Young

The centre of gravity of Australian brain stem cell research has undergone a major shift with a change of residence by star researcher Prof Perry Bartlett and a large number of his team.


Gene database study backs 'privacy guardians'

29 August, 2002 by Pete Young

A new class of "privacy guardians" for genetic research databases and new laws requiring private sector researchers to conform to public sector ethical guidelines are two likely outcomes of a major Australian inquiry into the protection of genetic information.


Investment feature: can we manage?

27 August, 2002 by David Binning

While many people are speculating as to whether Australia may become the next major hub for international biotech, questions are being asked of our local entrepreneurs and whether they have what it takes to turn IP into gold.


Bioinformatics a proving ground for IBM: Jasinski

26 August, 2002 by David Braue

New techniques for generating large amounts of biology-related data have given IT vendors new momentum in penetrating this traditionally low-tech segment of scientific research, a key IBM researcher told attendees at AusBiotech 2002 in Melbourne last week.


Bionomics and Hybrigen explain their partnership

26 August, 2002 by Melissa Trudinger

One of the more interesting collaborations between an Australian biotechnology company and a US company is the alliance between Adelaide genomics company Bionomics and proteomics company Hybrigen, based in Texas.


New technologies let researchers think outside the square

23 August, 2002 by Melissa Trudinger

Just one in-house technology is not enough, if you're a company that's always looking for new ways to boost your drug discovery and manufacturing capabilities, delegates to this week's AusBiotech conference were told.


Combinomics looks to sequence the unsequenceable

23 August, 2002 by Pete Young

An Australian-developed technique for sequencing previously intractable regions of genomes is attracting increasing financial backing.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd